Q1 2024 Regeneron Reports First Quarter 2024 Financial and Operating Results Regeneron Pharmaceuticals Q1 2024 Earnings Conference Call Regeneron May 2024 Corporate Presentation 2.1 MB Form 10-Q Annual Reports Date Title 2023 Annual Report 2023 Annual Report Proxy Statements Date Title 2024 Proxy Statement 2024 Proxy Statement Form 10-K Filing date View Feb 05, 2024 View HTML 0001804220-24-000009.pdf 0001804220-24-000009.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Feb 06, 2023 View HTML 0001804220-23-000008.pdf 0001804220-23-000008.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View May 02, 2024 View HTML 0001804220-24-000017.pdf 0001804220-24-000017.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Nov 02, 2023 View HTML 0001804220-23-000031v2.pdf 1.2 MB 0001804220-23-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Interactive Analyst Center Interactive and downloadable financial data for investors and analysts View Analyst Center